Clinical Trial Update: SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SCT200 injections in patients with head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• SCT200

Snippet

Sponsor: Shi Yuankai | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN